A detailed history of Meeder Advisory Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Meeder Advisory Services, Inc. holds 3,569 shares of NVO stock, worth $311,823. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,569
Previous 6,190 42.34%
Holding current value
$311,823
Previous $884 Million 51.91%
% of portfolio
0.03%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$119.07 - $145.42 $312,082 - $381,145
-2,621 Reduced 42.34%
3,569 $425 Million
Q2 2024

Aug 08, 2024

BUY
$122.71 - $146.91 $759,574 - $909,372
6,190 New
6,190 $884 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Meeder Advisory Services, Inc. Portfolio

Follow Meeder Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Meeder Advisory Services, Inc. with notifications on news.